Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
University of California, San Diego
Medical College of Wisconsin
Essen Biotech
University of Alberta
University of Michigan Rogel Cancer Center
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
University of Texas Southwestern Medical Center
Barbara Ann Karmanos Cancer Institute
First Affiliated Hospital of Zhejiang University
Stanford University
Ottawa Hospital Research Institute
Essen Biotech
Cancer Research UK
University of Pittsburgh
Thomas Jefferson University
Chinese PLA General Hospital
Mayo Clinic
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Children's Hospital of Philadelphia
University of Sao Paulo
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
Chinese PLA General Hospital
Icahn School of Medicine at Mount Sinai
University of Nebraska
University of Nebraska
University Hospital Southampton NHS Foundation Trust
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
Technical University of Munich
Columbia University
Fred Hutchinson Cancer Center
Chinese PLA General Hospital
M.D. Anderson Cancer Center
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
M.D. Anderson Cancer Center
Sun Yat-sen University
Columbia University
City of Hope Medical Center
La Raza Medical Center
Weill Medical College of Cornell University
Chinese PLA General Hospital